Evotec stock: November 5 results put 2026 outlook in focus

Company: Evotec SE
ISIN: DE0005664809
Trading venue: Lang &amp; Schwarz
Quote: 2.80 euros on Sunday, November 1, 2026, at 17:03 CET

Published on 11/01/2026 at 17:05 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Evotec stock faces a key results date on November 5. Preliminary figures already pointed to revenue of 465.0 million euros.

Results And Guidance Ahead

Evotec will publish its first-nine-month results and provide a business update on Thursday, November 5, 2026.
Preliminary nine-month revenue was about 465.0 million euros, while adjusted EBITDA was about negative 42.8 million euros.
Management reaffirmed full-year revenue guidance of about 570 million to 610 million euros.

Evotec SE, DE0005664809, Illustration mit AI erstellt.

Evotec will publish its results for the first nine months of 2026 on Thursday, November 5, alongside a business update. The company is scheduled to hold an English-language webcast and conference call at 2:00 pm CET.

In its official ad hoc release, Evotec said preliminary revenue for the first nine months reached about 465.0 million euros. Adjusted EBITDA was about negative 42.8 million euros, with the company attributing the difference to the phasing of consensus estimates.

Guidance Sets The Near-Term Frame

Evotec reaffirmed full-year 2026 revenue guidance of about 570 million to 610 million euros, or 595 million to 635 million euros at constant exchange rates. Adjusted EBITDA guidance remains at about negative 70 million to negative 105 million euros, with the constant-exchange-rate range at negative 60 million to negative 90 million euros.

Evotec stock traded at 2.80 euros on Lang & Schwarz at 17:03 CET on Sunday, November 1, 2026. Investors can follow the real-time quote of Evotec stock.